The effect of patient education on compliance with drug therapy for rheumatoid arthritis

Completed

• Conditions: Rheumatoid arthritis; Other rheumatoid arthritis; Musculoskeletal Diseases

• Registration Number: ISRCTN68585617
• Lead Sponsor: Arthritis Research Campaign (ARC) (UK)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2002-07-30
• Last Update Posted: 13 January 2015

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

1. All patients deemed by the consultant rheumatologist to require dPenicillamine (DPA) as their disease modifying anti-rheumatic drug (DMARD)
2. Over 18 years of age
3. Plasma Viscosity (PV) =1.75
4. Cysteine rich protein (CRP) =10
5. Articular index 15 or less than
6. Morning stiffness =45 min
7. Pain level moderate/severe

Exclusion Criteria

Does not meet inclusion criteria

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
It is anticipated that effective education will enhance compliance leading to better drug utilisation and improved patient outcome.

Secondary Outcome Measures

Name	Time	Method
ot provided at time of registration